Observations that pathogen-specific IgG levels may not be affected by CD19-CAR-T cell therapy in adults informed our hypothesis that IgG antibodies against vaccine-preventable infections may be preserved after CD19-CAR-T cell therapy (11, 12, 19). This evidence concerns the gene CD19 and infection.